Boston Scientific Other Non-Current Assets increased by 1.9% to $1.87B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.4%, from $1.75B to $1.87B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows relatively stable performance with a -0.6% CAGR.
Significant changes may indicate shifts in accounting estimates, tax positions, or non-core asset holdings.
This category includes long-term assets that do not fit into specific classifications like PP&E or intangibles, such as...
Standard line item in most balance sheets, often labeled 'Other non-current assets'.
non_current_assets_other_assets_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.44B | $1.41B | $1.38B | $1.57B | $1.60B | $1.50B | $1.48B | $1.60B | $1.61B | $1.53B | $1.60B | $1.55B | $1.64B | $1.75B | $1.83B | $1.86B | $1.83B | $1.87B |
| QoQ Change | — | -11.4% | -2.4% | -2.5% | +14.1% | +2.1% | -6.4% | -1.2% | +7.6% | +0.6% | -4.6% | +4.2% | -2.8% | +5.9% | +6.8% | +4.6% | +1.6% | -1.7% | +1.9% |
| YoY Change | — | — | — | — | -3.7% | +10.9% | +6.4% | +7.8% | +1.7% | +0.2% | +2.1% | +7.7% | -2.8% | +2.3% | +14.6% | +14.9% | +20.2% | +11.6% | +6.4% |